SELENIOUS ACID injection, solution USA - engelsk - NLM (National Library of Medicine)

selenious acid injection, solution

american regent, inc. - selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b) - selenious acid injection is indicated in adult and pediatric patients as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. none. risk summary administration of the recommended dose of selenious acid injection in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with intravenous selenious acid. the estimated background risk of major birth defects and miscarriage for the indicated populations are unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. n the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical considerations disease-associated maternal and/or embryo-fetal risk deficiency of trace elements, including selenium, is associated with adverse pregnancy and fetal outcomes. pregnant women have an increased metabolic demand for trace elements, including selenium. parenteral nutrition with selenium should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake. risk summary selenium is present in human milk. administration of the approved recommended dose of selenious acid injection in parenteral nutrition is not expected to cause harm to a breastfed infant. there is no information on the effects of selenious acid on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for selenious acid injection and any potential adverse effects on the breastfed infant from selenious acid injection or from the underlying maternal condition. selenious acid injection is approved for use in the pediatric population, including neonates, as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. safety and dosing recommendations in pediatric patients are based on clinical experience [see dosage and administration (2.5)] . because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with selenious acid injection may be at higher risk of aluminum toxicity [see warnings and precautions (5.3)]. reported clinical experience with intravenous selenious acid has not identified a difference in selenium requirements between elderly and younger patients. in general, dose selection should be individualized based on the patient’s clinical condition, nutritional requirements, and additional nutritional intake provided orally or enterally to the patient.

SELENIUM injection, solution USA - engelsk - NLM (National Library of Medicine)

selenium injection, solution

american regent, inc. - selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - selenious acid 65.4 ug in 1 ml - selenium injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (tpn). administration of selenium in tpn solutions helps to maintain plasma selenium levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. selenium injection should not be given undiluted by direct injection into a peripheral vein because of the potential for infusion phlebitis.

SELENIOUS ACID injection, solution USA - engelsk - NLM (National Library of Medicine)

selenious acid injection, solution

woodward pharma services llc - selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b) - selenium injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (tpn). administration of selenium in tpn solutions helps to maintain plasma selenium levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. selenium injection should not be given undiluted by direct injection into a peripheral vein because of the potential for infusion phlebitis.

MICRO+ TE PEDIATRIC SOLUTION Canada - engelsk - Health Canada

micro+ te pediatric solution

sandoz canada incorporated - manganese (manganese sulfate); iodide (sodium iodide); selenium (selenious acid); zinc (zinc sulfate); copper (cupric sulfate) - solution - 1mcg; 1mcg; 2mcg; 250mcg; 20mcg - manganese (manganese sulfate) 1mcg; iodide (sodium iodide) 1mcg; selenium (selenious acid) 2mcg; zinc (zinc sulfate) 250mcg; copper (cupric sulfate) 20mcg

MICRO PLUS 5 CONCENTRATE LIQUID Canada - engelsk - Health Canada

micro plus 5 concentrate liquid

sandoz canada incorporated - manganese (manganese sulfate); chromium (chromic chloride); selenium (selenious acid); copper (cupric sulfate); zinc (zinc sulfate) - liquid - 0.5mg; 10mcg; 60mcg; 1mg; 5mg - manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg; selenium (selenious acid) 60mcg; copper (cupric sulfate) 1mg; zinc (zinc sulfate) 5mg - replacement preparations

MICRO PLUS 6    (CONCENTRATE) LIQUID Canada - engelsk - Health Canada

micro plus 6 (concentrate) liquid

sandoz canada incorporated - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride); selenium (selenious acid); iodine (sodium iodide) - liquid - 5mg; 1mg; 0.5mg; 10mcg; 60mcg; 75mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg; selenium (selenious acid) 60mcg; iodine (sodium iodide) 75mcg - replacement preparations

M.T.E.-6 CONCENTRATED SOLUTION Canada - engelsk - Health Canada

m.t.e.-6 concentrated solution

pharmaceutical partners of canada inc - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride); selenium (selenious acid); iodide (sodium iodide) - solution - 5mg; 1mg; 0.5mg; 10mcg; 60mcg; 75mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg; selenium (selenious acid) 60mcg; iodide (sodium iodide) 75mcg - replacement preparations

SELEPEN SOLUTION Canada - engelsk - Health Canada

selepen solution

pharmaceutical partners of canada inc - selenium (selenious acid) - solution - 40mcg - selenium (selenious acid) 40mcg - replacement preparations

硒酵母片 片剂 50μg(以每片70mg硒酵母中含硒量计) Kina - kinesisk - CFDA (药监局 - 中国食品和药物管理局)

硒酵母片 片剂 50μg(以每片70mg硒酵母中含硒量计)

牡丹江灵泰药业股份有限公司 - 片剂 - 50μg(以每片70mg硒酵母中含硒量计)